We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Prediction: these FTSE 250 stocks could be among 2025’s big winners

Finding the coming year’s FTSE 250 winners isn’t an easy task, but we’re thinking about it at this time of year, aren’t we?

| More on:
piggy bank, searching with binoculars

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m hoping for a return to growth for the FTSE 250 in 2025 after a disappointing few years. But which stocks do I think might lead the mid-cap index? My eyes have fallen on these three.

Healthcare income

I think 2025 could be the year when some of the FTSE 250’s undervalued real estate investment trusts (REITs) could make a comeback. Primary Health Properties (LSE: PHP) is one, after its share price ended 2024 on a bit of a slide.

XXX

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

The company owns healthcare facilities that it rents out largely to GPs, many in the NHS. With relatively reliable rental income, success doesn’t depend on property valuations.

Uncertain valuation

I think its assets look good anyway. At the 2024 interim, adjusted net tangible assets per share stood at 105p. The share price is just 89p at the time of writing.

That’s a non-standard accounting measure, and property valuations have been volatile, so there’s risk there.

But with strong earnings growth forecast for 2025, and a forward dividend yield of 8.2%, I think this trust could deserve a higher rating in 2025.

Cheap TV

The first half of 2024 made it seem like an ITV (LSE: ITV) recovery was on, though it cooled off. We’re looking at a decent 12-month gain of 17%, but I still think the shares could be too cheap.

The tough economy is putting the squeeze on advertising spend. But we just heard that December inflation was down, which hopefully bodes well.

The firm’s Q3 update spoke of revenue being impacted by the phasing of deliveries and the 2023 writers’ and actors’ strike in the US. And that gave the share price a hit on the day.

Forward, not back

ITV still said “We remain on track to deliver at least £750 million of digital revenues in 2026“. And it sees only a small fall in 2024 ITVX streaming revenue.

We have a forward dividend yield of 7%, with an expected FY 2024 price-to-earnings (P/E) ratio of just nine.

There’s an earnings fall forecast for 2025, which could keep the shares down. But if we see early signs of the growth predicted for 2026, I think ITV could beat the FTSE 250 this year.

Plastic, fantastic

At polymer specialist Victrex (LSE: VCT), seeing a five-year share price fall of 57% and a trailing P/E of 50 made me pause for breath.

Looking closer though, I see things I like, including a forecast 6.8% dividend yield.

After a few years of falling earnings, forecasts show a return to growth starting with a boost in 2025. They put the forward P/E at 17, dropping as low as 11 by 2027.

Protective moat

On these valuation measures, I think we could have solid growth characteristics. But I want to see a competitive advantage to back that up.

Victrex makes high-performance polymers for safety-critical uses, and a number of them are patented products. That looks like a safety moat.

The biggest risk for me personally is that I haven’t researched the company properly yet. But I think investors looking for 2025 winners should consider doing so.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended ITV, Primary Health Properties Plc, and Victrex Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »